To the Editor {#s1}
=============

The recently published manuscript by Gehrie and colleagues^[@CIT0001]^ highlights the varying pressures faced by academic medical centers during the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Building on their benchmarks for preparedness, I would further advocate for blood banks to focus on the preanalytic total number of specimens received to better understand and anticipate the evolving pressures that individual diagnostic laboratories face in the ongoing pandemic ****[Figure 1](#F1){ref-type="fig"}****. To best determine blood inventory stocking levels, the trend for total number of specimens received can be overlaid onto state, county, and regional data related to cessation of elective surgical procedures.^[@CIT0002]^ These data can help guide inventory level management during the pandemic, noting that there remains a significant challenge for blood collection centers to maintain critical nationwide blood inventories.^[@CIT0003]^

![Total number of blood bank specimens received by Vanderbilt University Medical Center each month.](aqaa129f0001){#F1}

As the authors point out, determining blood inventory stocks at Level 1 trauma centers during summer months demonstrates an additional complexity.^[@CIT0001]^ I agree that daily review of blood products used during massive transfusion protocol activations can serve as an additional tool to communicate the appropriate use of limited biologic products ****[Table 1](#T1){ref-type="table"}****.^[@CIT0004]^

###### 

Total Number of Adult Massive Transfusion Protocol Activations at Vanderbilt University Medical Center

         Jan   Feb   Mar   Apr   May   Jun   Jul   Aug   Sep   Oct   Nov   Dec
  ------ ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- -----
  2018   31    16    12    21    24    22    13    27    17    10    25    20
  2019   11    10    16    16    19    21    24    30    28    20    19    20
  2020   17    19    16    15    32                                        

The authors are to be congratulated for their important contribution to the medical literature, which helps to ensure that scarce medical resources such as blood are utilized in an evidence-based fashion while maintaining adequate supply lines.

The Authors' Reply {#s2}
==================

We greatly appreciate the letter by Dr Booth and the provision of data from Vanderbilt University Medical Center, which shows the impact of the coronavirus disease 2019 (COVID-19) pandemic on a high-volume transfusion service in Nashville, TN. One point that this discussion raises is the importance of developing modalities to rapidly gather and aggregate real-time blood utilization and blood availability data during a crisis. The pandemic has exacerbated the need for these data, as blood needs are changing so rapidly that close coordination between suppliers and transfusion services is essential. Even after the pandemic, it is likely that sharing such data would help with transfusion medicine quality activities, including performance benchmarking for transfusion services and blood suppliers.
